Hims & Hers Health, Inc.
HIMS- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001773751
In the last 90 days, Hims & Hers Health, Inc. insiders filed 0 open-market purchases and 12 sales; 506 institutions reported holding it in 13F filings for Q2 2026, worth $5.39B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Hims & Hers Health, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 512
- +8 vs. Q2 2025
- Shares held
- 200.0M
- +27.8M (+16.2%) vs. Q2 2025
- Total value
- $11.3B
- +$2.76B (+32.1%) vs. Q2 2025
- New holders
- 103
- 202 more added
- Sold out
- 95
- 152 more reduced
7 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HIMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 506 | $5.39B |
| Q1 2026 | 436 | $3.10B |
| Q4 2025 | 487 | $5.96B |
| Q3 2025 | 512 | $11.3B |
| Q2 2025 | 511 | $8.75B |
| Q1 2025 | 431 | $4.73B |
| Q4 2024 | 395 | $3.98B |
| Q3 2024 | 309 | $2.54B |
| Q2 2024 | 298 | $2.75B |
| Q1 2024 | 244 | $1.97B |
| Q4 2023 | 197 | $1.11B |
| Q3 2023 | 192 | $748.8M |
| Q2 2023 | 190 | $1.25B |
| Q1 2023 | 189 | $1.18B |
| Q4 2022 | 156 | $676.5M |
| Q3 2022 | 152 | $528.6M |
| Q2 2022 | 138 | $404.1M |
| Q1 2022 | 132 | $418.1M |
| Q4 2021 | 139 | $458.7M |
| Q3 2021 | 111 | $319.1M |
| Q2 2021 | 86 | $592.9M |
| Q1 2021 | 81 | $693.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Hims & Hers Health, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Raleigh Capital Management Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| West Oak Capital, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Clear Street LLC | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Avantax Advisory Services, Inc. | – | – | – | – | Not filed |
| Total Wealth Planning & Management, Inc. | – | – | – | – | Not filed |
| Atria Wealth Solutions, Inc. | – | – | – | – | Not filed |
| Talon Private Wealth, LLC | – | – | – | – | Not filed |